Expression of tissue factor and tissue factor pathway inhibitor in microparticles and subcellular fractions of normal and malignant prostate cell lines

Blood Coagulation and Fibrinolysis

Volumn 24, Issue 3, 2013, Pages 339-343

  Lwaleed, Bashir A ^a   Lam, Lilian ^b   Lasebai, Muayed ^c   Cooper, Alan J ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

cancer; cell lines; microparticles; prostate; tissue factor; tissue factor pathway inhibitor

Indexed keywords

THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL FRACTIONATION; CELL MEMBRANE; CELL NUCLEUS; COMPARATIVE STUDY; CULTURE MEDIUM; CYTOSOL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCOAGULABILITY; IMMUNOCYTOCHEMISTRY; LIMIT OF DETECTION; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; TUMOR CELL;

CELL LINE, TUMOR; CELL MEMBRANE; CELL NUCLEUS; CELL-DERIVED MICROPARTICLES; CYTOSOL; GENE EXPRESSION; HUMANS; LIPOPROTEINS; MALE; PROSTATE; PROSTATIC NEOPLASMS; THROMBOPHILIA; THROMBOPLASTIN; THROMBOSIS;

EID: 84875862248     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32835e98a6     Document Type: Article

References (31)

1. Khorana AA. Cancer and coagulation. Am J Hematol 2012; 87 (Suppl 1): S82-S87.
2. Akl EA, Vasireddi SR, Gunukula S, Barba M, Sperati F, Terrenato I, et al. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Cochrane Database Syst Rev 2011; 6:CD006649.
3. Sack GH, Levin J, Bell WR. Trousseau's syndrome and other manifestations of chronic DIC in patients with neoplasms. Medicine 1977; 56:1-37.
4. Adamson AS, Luckert P, Pollard M, Snell ME, Amirkhosravi M, Francis JL. Procoagulant activity may be a marker of the malignant phenotype in experimental prostate cancer. Br J Cancer 1994; 69:286-290. (Pubitemid 24046551)
5. Haubold K, Rink M, Spath B, Friedrich M, Chun FK, Marx G, et al. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer. Thromb Haemost 2009; 101:1147-1155.
6. Langer F, Chun FK, Amirkhosravi A, Friedrich M, Leuenroth S, Eifrig B, et al. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers. Thromb Haemost 2007; 97:464-470. (Pubitemid 46437810)
7. Zemanova P, Opatrny K, Vit L, Sefrna F. Tissue factor, its inhibitor, and the thrombogenicity of two new synthetic membranes. Artif Organs 2005; 29:651-657. (Pubitemid 41602843)
8. Diamant M, Tushuizen ME, Sturk A, Nieuwland R. Cellular microparticles: new players in the field of vascular disease? Eur J Clin Invest 2004; 34:392-401. (Pubitemid 38859560)
9. Yu JL, Rak JW. Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells. J Thromb Haemost 2004; 2:2065-2067. (Pubitemid 40192770)
10. Iversen N, Lindahl AK, Abildgaard U. Elevated plasma levels of the factor Xa-TFPI complex in cancer patients. Thromb Res 2002; 105:33-36. (Pubitemid 34178305)
11. Iversen N, Lindahl AK, Abildgaard U. Elevated TFPI in malignant disease: relation to cancer type and hypercoagulation. Br J Haematol 1998; 102:889-895. (Pubitemid 28410516)
12. Lwaleed BA, Francis JL, Chisholm M. Monocyte tissue factor levels in patients with urological tumours: an association between tumour presence and progression. BJU Int 1999; 83:476-482. (Pubitemid 29151176)
13. Lwaleed BA, Francis JL, Chisholm M. Urinary tissue factor levels in patients with bladder and prostate cancer. Eur J Surg Oncol 2000; 26:44-49. (Pubitemid 30102822)
14. Aleksandrov L, Mengos A, Chang X, Aleksandrov A, Riordan Jr. Differential interactions of nucleotides at the two nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 2001; 276:12918-12923.
15. Fo? rster Y, Meye A, Albrecht S, Schwenzer B. Tissue factor and tumor: clinical and laboratory aspects. Clinica Chimica Acta 2006; 364:12-21. (Pubitemid 43120625)
16. Rickles FR, Patierno S, Fernandez PM. Tissue factor, thrombin, and cancer. Chest 2003; 124:58-68.
17. Callander NS, Varki N, Rao LV. Immunohistochemical identification of tissue factor in solid tumors. Cancer 1992; 70:1194-1201.
18. Fo? rster Y, Meye A, Albrecht S, Schwenzer B. Tissue specific expression and serum levels of human tissue factor in patients with urological cancer. Cancer Lett 2003; 193:65-73. (Pubitemid 36416613)
19. Akashi T, Furuya Y,Ohta S, Fuse H. Tissue factor expression and prognosis in patients with metastatic prostate cancer. Urology 2003; 62:1078-1082. (Pubitemid 37510095)
20. Abdulkadir SA, Carvalhal GF, Kaleem Z, Kisiel W, Humphrey PA, Catalona WJ, et al. Tissue factor expression and angiogenesis in human prostate carcinoma. Hum Pathol 2000; 31:443-447. (Pubitemid 30262866)
21. Lwaleed BA, Vayro S, Racusen LC, Cooper AJ. Tissue factor expression by a human kidney proximal tubular cell line in vitro: a model relevant to urinary tissue factor secretion in disease? J Clin Pathol 2007; 60:762-767. (Pubitemid 47056904)
22. Stewart AB, Anderson W, Delves G, Lwaleed BA, Birch B, Cooper A. Prostasomes: a role in prostatic disease? BJU Int 2004; 94:985-989. (Pubitemid 39577081)
23. Ronquist G, Nilsson BO. The Janus-faced nature of prostasomes: their pluripotency favours the normal reproductive process and malignant prostate growth. Prostate Cancer Prostatic Dis 2004; 7:21-31. (Pubitemid 38443527)
24. Delves GH, Stewart AB, Lwaleed BA, Cooper AJ. In vitro inhibition of angiogenesis by prostasomes. Prostate Cancer Prostatic Dis 2005; 8:174-178. (Pubitemid 43118082)
25. Delves GH, Goyal A, Lwaleed BA, Cooper AJ. Seminal prostasomes inhibit the angiogenesis activity of rat aortic rings. Prostate Cancer Prostatic Dis 2006; 9:444-447. (Pubitemid 44843140)
26. Hamada K, Kuratsu J, Saitoh Y, Takeshima H, Nishi T, Ushio Y. Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer 1996; 77:1877-1883. (Pubitemid 26125190)
27. Kakkar AK, Lemoine NR, Scully MF, Tebbutt S, Williamson RC. Tissue factor expression correlates with histological grade in human pancreatic cancer. Br J Surg 1995; 82:1101-1104.
28. Gordon SG, Franks JJ, Lewis B. Cancer procoagulant A: a factor X activating procoagulant from malignant tissue. Thromb Res 1975; 6:127- 137.
29. Dietzen DJ, Jack GG, Page KL, Tetzloff TA, Hall CL, Mast AE. Localization of tissue factor pathway inhibitor to lipid rafts is not required for inhibition of factor VIIa/tissue factor activity. Thromb Haemost 2003; 89:65-73. (Pubitemid 36149794)
30. Ferna'ndez JA, Heeb MJ, Radtke KP, Griffin JH. Potent blood coagulant activity of human semen due to prostasome-bound tissue factor. Biol Reprod 1997; 56:757-763. (Pubitemid 27084113)
31. Lwaleed B, Jackson C, Greenfield R, Stewart A, Delves G, Birch B, et al. Seminal tissue factor revisited. Int J Androl 2006; 29:360-367. (Pubitemid 43383403)